Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiang, Yan Ting
Wang, James Z. L.
Thu, Kelsie L.
Lam, Wan L.
Shah, Sohrab P.
Collins, Colin C.
Helgason, Cheryl D.
Funding for this research was provided by:
Canadian Cancer Society Research Institute
Canadian Institutes of Health Research (CA)
Terry Fox Research Institute
Prostate Cancer Canada
Michael Smith Foundation for Health Research
BC Cancer Foundation